Clinical Trial: Is Spontaneous Bacterial Peritonitis Still Responding to 3rd Generation Cephalosporins?

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Is Spontaneous Bacterial Peritonitis Still Responding to 3rd Generation Cephalosporins?

Brief Summary:

Current European and most other international guidelines recommend the use of a third-generation cephalosporin as the first choice, or amoxicillin-clavulanate acid or fluoroquinolones as an alternative choice .

These recommendations are based mainly on clinical trials that were very often conducted a decade or more ago, and on the assumption that E. coli would be involved in nearly half of the cases.

The microbial etiology of SBP remains relatively constant; however, the antibiotic resistance rate especially for third-generation cephalosporins (including cefotaxime and ceftazidime), ciprofloxacin, and ofloxacin increased dramatically .